Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Oramed Pharmaceuticals stock

Learn how to easily invest in Oramed Pharmaceuticals stock.

Oramed Pharmaceuticals is a biotechnology business based in the US. Oramed Pharmaceuticals shares (ORMP) are listed on the NASDAQ and all prices are listed in US Dollars.

How to buy Oramed Pharmaceuticals stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – ORMP. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Promoted for options trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 in stock when you fund a new account within 30 days

Promoted for all-in-one investing

M1 Finance

  • Commission-free stock and ETF trades
  • No management fees
  • Customizable portfolios with automatic rebalancing

Oramed Pharmaceuticals stock price (NASDAQ: ORMP)

Use our graph to track the performance of ORMP stocks over time.

Oramed Pharmaceuticals shares at a glance

Information last updated 2023-06-04.
Latest market close$4.02
52-week range$1.81 - $13.73
50-day moving average $2.83
200-day moving average $5.35
Wall St. target price$13.77
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.75

Buy Oramed Pharmaceuticals stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
Stocks, Options, ETFs, Cryptocurrency, Futures
Get $100 - $2,000
when you you open and fund an account with $5,000 to $100,000+
Highly commended for Best Derivatives Trading Platform award.
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000 in stock
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
M1 Finance
Stocks, ETFs
Get $75 - $500
when you sign up and deposit min. $10,000 within 14 days. Terms and conditions apply
Build a custom portfolio of stocks and ETFs with automatic rebalancing.
Finder Award
Stocks, Options, ETFs, Cryptocurrency
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency, Alternatives, Treasury Bills
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Earn a 5.4% yield with government-backed Treasury bills.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs, Treasury Bills
Get $50 - $700
when you open and fund an account with $5,000 - $250,000+
Pay no commissions on stocks, ETFs, mutual funds and options.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy Oramed Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Oramed Pharmaceuticals price performance over time

Historical closes compared with the close of $4.02 from 2023-06-02

1 week (2023-05-26) 1.52%
1 month (2023-05-04) 47.25%
3 months (2023-03-03) 87.85%
6 months (2022-12-02) -53.53%
1 year (2022-06-02) -14.29%
2 years (2021-06-02) -66.80%
3 years (2020-06-04) 17.20%
5 years (2018-06-04) 7.76

Oramed Pharmaceuticals financials

Revenue TTM $2.7 million
Gross profit TTM $2.7 million
Return on assets TTM -13.01%
Return on equity TTM -19.64%
Profit margin 0%
Book value $3.78
Market capitalisation $160.9 million

TTM: trailing 12 months

Oramed Pharmaceuticals share dividends

We're not expecting Oramed Pharmaceuticals to pay a dividend over the next 12 months.

Have Oramed Pharmaceuticals's shares ever split?

Oramed Pharmaceuticals's shares were split on a 1:12 basis on 23 January 2013. So if you had owned 12 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Oramed Pharmaceuticals shares – just the quantity. However, indirectly, the new 1100% higher share price could have impacted the market appetite for Oramed Pharmaceuticals shares which in turn could have impacted Oramed Pharmaceuticals's share price.

Oramed Pharmaceuticals share price volatility

Over the last 12 months, Oramed Pharmaceuticals's shares have ranged in value from as little as $1.81 up to $13.73. A popular way to gauge a stock's volatility is its "beta".

ORMP.US volatility(beta: 1.81)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Oramed Pharmaceuticals's is 1.8121. This would suggest that Oramed Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Oramed Pharmaceuticals overview

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. The company's product portfolio includes ORMD-0801 Type 2, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes; ORMD-0801, Phase 2 oral insulin capsule for non-alcoholic steatohepatitis, a progressive liver diseases; and ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York. .

Frequently asked questions

What percentage of Oramed Pharmaceuticals is owned by insiders or institutions?
Currently 5.446% of Oramed Pharmaceuticals shares are held by insiders and 12.638% by institutions.
When does the fiscal year end for Oramed Pharmaceuticals?
Oramed Pharmaceuticals's fiscal year ends in August.
Where is Oramed Pharmaceuticals based?
Oramed Pharmaceuticals's address is: 1185 Avenue of the Americas, New York, NY, United States, 10036
What is Oramed Pharmaceuticals's ISIN number?
Oramed Pharmaceuticals's international securities identification number is: US68403P2039
What is Oramed Pharmaceuticals's CUSIP number?
Oramed Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 68403P104

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site